EUVIMEDEUVIMED entdecken
Crossref

Development of LGR5-targeted antibody drugs and their prospects in tumor therapy

Tian-Hao ZHANG, Tao LI, Wei-Hong TAO

Chinese Bulletin of Life Sciences · 01.08.2026

DOI: 10.3724/cbls.2026110 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chinese Bulletin of Life Sciences, online erschienen am 10.08.2026. Verfasst von Tian-Hao ZHANG und 2 weiteren Autor:innen. Die Arbeit nennt 71 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

ZHANG, T., LI, T., & TAO, W. (2026). Development of LGR5-targeted antibody drugs and their prospects in tumor therapy. Chinese Bulletin of Life Sciences. https://doi.org/10.3724/cbls.2026110

Vancouver

ZHANG T, LI T, TAO W. Development of LGR5-targeted antibody drugs and their prospects in tumor therapy. Chinese Bulletin of Life Sciences. 2026. doi:10.3724/cbls.2026110

BibTeX
@article{ZHANG2026,
  author = {ZHANG, Tian-Hao and LI, Tao and TAO, Wei-Hong},
  title = {Development of LGR5-targeted antibody drugs and their prospects in tumor therapy},
  journal = {Chinese Bulletin of Life Sciences},
  year = {2026},
  doi = {10.3724/cbls.2026110}
}
Kostenlos starten →